Synonyms: BMN-673 | BMN673 | Talzenna®
talazoparib is an approved drug (FDA (2018), EMA (2019))
Compound class:
Synthetic organic
Comment: Talazoparib is a PARP inhibitor [8], inhibiting both PARP1 and PARP2 [1,8]. The compound is bioavailable as the tosylate salt (PubChem CID 56966514).
|
|
Classification ![]() |
|
Compound class | Synthetic organic |
Approved drug? | Yes (FDA (2018), EMA (2019)) |
Approved drug? | Yes. FDA (2018) | EMA (2019) |
International Nonproprietary Names ![]() |
|
INN number | INN |
9868 | talazoparib |
Synonyms ![]() |
BMN-673 | BMN673 | Talzenna® |
Database Links ![]() |
|
BindingDB Ligand | 50084621 |
ChEMBL Ligand | CHEMBL3137320 |
DrugBank Ligand | DB11760 |
GtoPdb PubChem SID | 252166525 |
PubChem CID | 135565082 |
Search Google for chemical match using the InChIKey | IUEWAGVJRJORLA-HZPDHXFCSA-N |
Search Google for chemicals with the same backbone | IUEWAGVJRJORLA |
Search PubMed clinical trials | talazoparib |
Search PubMed titles | talazoparib |
Search PubMed titles/abstracts | talazoparib |
SynPHARM |
81953 (in complex with poly(ADP-ribose) polymerase 1) 81954 (in complex with poly(ADP-ribose) polymerase 2) |
UniChem Compound Search for chemical match using the InChIKey | IUEWAGVJRJORLA-HZPDHXFCSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | IUEWAGVJRJORLA-HZPDHXFCSA-N |
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖